Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

High-resolution melting analysis for mutation screening of RGSL1, RGS16, and RGS8 in breast cancer.

Wiechec E, Wiuf C, Overgaard J, Hansen LL.

Cancer Epidemiol Biomarkers Prev. 2011 Feb;20(2):397-407. doi: 10.1158/1055-9965.EPI-10-0514. Epub 2010 Dec 6.

2.

A fragile site within the HPC1 region at 1q25.3 affecting RGS16, RGSL1, and RGSL2 in human breast carcinomas.

Wiechec E, Overgaard J, Hansen LL.

Genes Chromosomes Cancer. 2008 Sep;47(9):766-80. doi: 10.1002/gcc.20578.

PMID:
18521847
3.

Screening of exon 11 of BRCA1 gene using the high resolution melting approach for diagnosis in Moroccan breast cancer patients.

El Khachibi M, Diakite B, Hamzi K, Badou A, Senhaji MA, Bakhchane A, Jouhadi H, Barakat A, Benider A, Nadifi S.

BMC Cancer. 2015 Feb 25;15:81. doi: 10.1186/s12885-015-1040-4.

4.

High-resolution melting analysis for rapid screening of BRCA1 and BRCA2 Spanish mutations.

de Juan I, Esteban E, Palanca S, Barragán E, Bolufer P.

Breast Cancer Res Treat. 2009 May;115(2):405-14. doi: 10.1007/s10549-008-0073-7. Epub 2008 Jun 5.

PMID:
18528753
5.

Determining the effectiveness of High Resolution Melting analysis for SNP genotyping and mutation scanning at the TP53 locus.

Garritano S, Gemignani F, Voegele C, Nguyen-Dumont T, Le Calvez-Kelm F, De Silva D, Lesueur F, Landi S, Tavtigian SV.

BMC Genet. 2009 Feb 17;10:5. doi: 10.1186/1471-2156-10-5.

6.

Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.

Durocher F, Labrie Y, Soucy P, Sinilnikova O, Labuda D, Bessette P, Chiquette J, Laframboise R, Lépine J, Lespérance B, Ouellette G, Pichette R, Plante M, Tavtigian SV, Simard J.

BMC Cancer. 2006 Sep 29;6:230.

7.

High resolution melting for mutation scanning of TP53 exons 5-8.

Krypuy M, Ahmed AA, Etemadmoghadam D, Hyland SJ; Australian Ovarian Cancer Study Group, DeFazio A, Fox SB, Brenton JD, Bowtell DD, Dobrovic A.

BMC Cancer. 2007 Aug 31;7:168.

8.

Mutational analysis of thirty-two double-strand DNA break repair genes in breast and pancreatic cancers.

Wang X, Szabo C, Qian C, Amadio PG, Thibodeau SN, Cerhan JR, Petersen GM, Liu W, Couch FJ.

Cancer Res. 2008 Feb 15;68(4):971-5. doi: 10.1158/0008-5472.CAN-07-6272.

9.

High-resolution DNA melting analysis for simultaneous mutation scanning and genotyping in solution.

Zhou L, Wang L, Palais R, Pryor R, Wittwer CT.

Clin Chem. 2005 Oct;51(10):1770-7.

10.

[Relationship between mutation of BRCA1 and susceptibility to early onset of breast cancer].

Meng J, Shi YR, Niu RF, Fu L.

Zhonghua Yi Xue Za Zhi. 2009 Jan 13;89(2):79-82. Chinese.

PMID:
19489266
11.

Mutation screening of the BRCA1 gene in sporadic breast cancer in southern Chinese populations.

Haitian Z, Yunfei L, Jian Z, Jian L, Qinghua L, Fuqiang W.

Breast. 2008 Dec;17(6):563-7. doi: 10.1016/j.breast.2008.08.003. Epub 2008 Oct 5.

PMID:
18835712
12.

A novel mutation screening system for Ehlers-Danlos Syndrome, vascular type by high-resolution melting curve analysis in combination with small amplicon genotyping using genomic DNA.

Naing BT, Watanabe A, Shimada T.

Biochem Biophys Res Commun. 2011 Feb 18;405(3):368-72. doi: 10.1016/j.bbrc.2011.01.011. Epub 2011 Jan 8.

PMID:
21219851
13.

Simultaneous mutation detection of three homoeologous genes in wheat by High Resolution Melting analysis and Mutation Surveyor.

Dong C, Vincent K, Sharp P.

BMC Plant Biol. 2009 Dec 4;9:143. doi: 10.1186/1471-2229-9-143.

14.

Optimizing high-resolution melting analysis for the detection of mutations of GPR30/GPER-1 in breast cancer.

Aihara M, Yamamoto S, Nishioka H, Inoue Y, Hamano K, Oka M, Mizukami Y.

Gene. 2012 Jun 15;501(2):118-26. doi: 10.1016/j.gene.2012.04.029. Epub 2012 Apr 16.

PMID:
22525040
15.

Detecting differential allelic expression using high-resolution melting curve analysis: application to the breast cancer susceptibility gene CHEK2.

Nguyen-Dumont T, Jordheim LP, Michelon J, Forey N, McKay-Chopin S; Kathleen Cuningham Foundation Consortium for Research into Familial Aspects of Breast Cancer, Sinilnikova O, Le Calvez-Kelm F, Southey MC, Tavtigian SV, Lesueur F.

BMC Med Genomics. 2011 May 11;4:39. doi: 10.1186/1755-8794-4-39.

16.

Investigation of the 1758G>C and 2880A>G variants within the NCOA3 gene in a breast cancer affected Australian population.

Gabrovska PN, Smith RA, O'Leary G, Haupt LM, Griffiths LR.

Gene. 2011 Aug 15;482(1-2):68-72. doi: 10.1016/j.gene.2011.05.001. Epub 2011 May 13.

PMID:
21601620
17.

Genetic contribution of GADD45A to susceptibility to sporadic and non-BRCA1/2 familial breast cancers: a systematic evaluation in Chinese populations.

Yu KD, Di GH, Li WF, Rao NY, Fan L, Yuan WT, Hu Z, Wu J, Shen ZZ, Huang W, Shao ZM.

Breast Cancer Res Treat. 2010 May;121(1):157-67. doi: 10.1007/s10549-009-0516-9. Epub 2009 Sep 2.

PMID:
19728081
18.

High frequency of somatic missense mutation of BRCA2 in female breast cancer from Taiwan.

Chen FM, Hou MF, Chang MY, Wang JY, Hsieh JS, Ou-Yang F, Huang TJ, Lin SR.

Cancer Lett. 2005 Apr 8;220(2):177-84.

PMID:
15766593
19.

Identification of ryanodine receptor 1 single-nucleotide polymorphisms by high-resolution melting using the LightCycler 480 System.

Grievink H, Stowell KM.

Anal Biochem. 2008 Mar 15;374(2):396-404. Epub 2007 Nov 21.

PMID:
18082125
20.

Comprehensive mutational analysis of BRCA1/BRCA2 for Korean breast cancer patients: evidence of a founder mutation.

Seong MW, Cho S, Noh DY, Han W, Kim SW, Park CM, Park HW, Kim SY, Kim JY, Park SS.

Clin Genet. 2009 Aug;76(2):152-60. doi: 10.1111/j.1399-0004.2009.01202.x. Epub 2009 Jul 28.

PMID:
19656164

Supplemental Content

Support Center